Moving the Goalposts for Blood Pressure — Time to Act

We often lament the lack of confirmatory studies that can either reassure us all that the previous evidence for a trialed intervention is robust or indicate that the evidence is questionable. Zhang and colleagues have conducted such a study — the STEP trial 1 — which in essence investigates the vera...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The New England journal of medicine Ročník 385; číslo 14; s. 1328 - 1329
Hlavní autor: Nelson, Mark R
Médium: Journal Article
Jazyk:angličtina
Vydáno: Boston Massachusetts Medical Society 30.09.2021
Témata:
Asymptomatic
Blood pressure
Cardiology
Cardiovascular disease
Clinical Practice
Coronary Disease
Heart attacks
Hospitalist
Hypertension
Myocardial Infarction
Nephrology
Patients
Prevention
Primary Care
Stroke
China
ISSN:0028-4793, 1533-4406, 1533-4406
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:We often lament the lack of confirmatory studies that can either reassure us all that the previous evidence for a trialed intervention is robust or indicate that the evidence is questionable. Zhang and colleagues have conducted such a study — the STEP trial 1 — which in essence investigates the veracity of the findings of the previous trial SPRINT, 2 but in an older cohort and in China, a country with a considerable burden of high blood pressure and stroke. The investigators have demonstrated impressive organizational skills in completing recruitment for such a large multicenter trial within a calendar year. As in . . .
Bibliografie:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMe2112992